Skip to content
DraconiticResearch
Search Sources API
197,783 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BYFrontiers in immunology

From TLS architecture to functional immune niches: division of labor among CAFs, HEVs, and antigen-presenting cells in cancer immunotherapy

  1. 1Department of Laboratory Medicine, Zigong First People’s Hospital , , ,
  2. 2Department of Oncology, Zigong First People’s Hospital , , ,

Related

  1. Programmable antigen-presenting scaffolds expand rare tumor-antigen-specific T cells from peripheral blood
    J. N. DeVilla, Y. Binenbaum, N. Cieri +10
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. Human Osteocytes Express MHC ClassII and Act as Non-classical Antigen-Presenting Cells During Bacterial Infection
    M. A. Hossain, D. Muratovic, Q. Sun +4
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  3. MHC II-expressing bone marrow megakaryocytes are noncanonical antigen-presenting cells and activate CD4+ T cells ex vivo
    Virginia Camacho, Karen G. Wang, Pavel Hanč +14
    Cell ReportsPeer-reviewedCC BY-NC-ND 4.0General biologyCrossref
  4. Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes
    N. R. Klug, E. H. A. Mbaye, S. Wang +13
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
  5. Non-canonical microproteins as targets for shared-antigen cancer immunotherapy
    Ivo Fierro-Monti
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
BibTeX
@article{xiao2026from,
  title = {{From TLS architecture to functional immune niches: division of labor among CAFs, HEVs, and antigen-presenting cells in cancer immunotherapy}},
  author = {Li Xiao and Hongbo Qiu and Honglin Luo},
  journal = {Frontiers in immunology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655546},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - From TLS architecture to functional immune niches: division of labor among CAFs, HEVs, and antigen-presenting cells in cancer immunotherapy
AU  - Li Xiao
AU  - Hongbo Qiu
AU  - Honglin Luo
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in immunology
UR  - https://europepmc.org/article/PMC/PMC13655546
SN  - 1664-3224
ER  -